The BRD9/7 Inhibitor TP-472 Blocks Melanoma Tumor Growth by Suppressing ECM-Mediated Oncogenic Signaling and Inducing Apoptosis is a research paper published in Cancers (2021). On theSindex it has a DataRank of 0. It has been cited 32 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R03CA230815-02
National Institutes of Health
Grant: R03CA248913-01
National Institutes of Health
Grant: 1R03CA221926-01
PERSONALIZED THERAPY FOR p16-DEFICIENT MELANOMA
National Institutes of Health
Grant: 5R01CA233481-02
PRECISION METABOLIC THERAPY OF p53 MUTANT TRIPLE NEGATIVE BREAST CANCERS
National Institutes of Health
Grant: 5R03CA248913-02
A Novel Anoikis Effector that Drives Ovarian Cancer Metastasis
National Institutes of Health
Grant: 5R03CA230815-02
A NOVEL EPIGENETIC IMMUNOTHERAPY FOR OVARIAN CANCER TREATMENT
FWCI
2.00
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals